Precirix
Biotechnology company developing precision radiopharmaceuticals in oncology
Brussels, Belgiumwww.precirix.com ↗
Total raised
€80M
€80,000,000
Funding rounds
1
Investors
9
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood35
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-16 | Series B | €80M | BioMed Partners,Forbion Capital Partners,Gimv,HealthCap,Inkef Capital,Jeito Capital+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Kpler€1.0BBelgium · Software